Team:MIT/Medals
From 2014.igem.org
(Difference between revisions)
Line 51: | Line 51: | ||
<br> A: This question arose at the beginning of our research journey, and continued to affect the direction of our project over the subsequent months. As a potential therapy for Alzheimer’s disease, our system would have to somehow be inserted into the human body. We considered several aspects of this process, and though we would never be performing it ourselves, we sought to design our system such that the safest, most effective, and most publicly acceptable method of delivery would be used. | <br> A: This question arose at the beginning of our research journey, and continued to affect the direction of our project over the subsequent months. As a potential therapy for Alzheimer’s disease, our system would have to somehow be inserted into the human body. We considered several aspects of this process, and though we would never be performing it ourselves, we sought to design our system such that the safest, most effective, and most publicly acceptable method of delivery would be used. | ||
<br> We began by interviewing professionals in the field of neuroscience and Alzheimer’s disease (see our <a href="https://2014.igem.org/Team:MIT/Outreach"> Outreach </a> page for more details). Armed with the industry opinion and our own research, we designed various methods of delivery and considered the pros and cons of each. | <br> We began by interviewing professionals in the field of neuroscience and Alzheimer’s disease (see our <a href="https://2014.igem.org/Team:MIT/Outreach"> Outreach </a> page for more details). Armed with the industry opinion and our own research, we designed various methods of delivery and considered the pros and cons of each. | ||
- | <br> We also considered the necessity of public approval of the system for it to be effective as a therapeutic. This led to the formulation of our <a href="https://2014.igem.org/Team:MIT/Delivery"> public opinion survey </a>. | + | <br> We also considered the necessity of public approval of the system for it to be effective as a therapeutic. This led to the formulation of our <a href="https://2014.igem.org/Team:MIT/Delivery" style="color:teal"> public opinion survey</a>. |
<br> Ultimately, these considerations aided us in designing the system that we have developed. We targeted the path of neuron delivery, but also explored numerous other delivery options.</dd></dl></li> | <br> Ultimately, these considerations aided us in designing the system that we have developed. We targeted the path of neuron delivery, but also explored numerous other delivery options.</dd></dl></li> | ||
</ol> | </ol> | ||
Line 77: | Line 77: | ||
<li><dl> | <li><dl> | ||
<dt><b>The description of each project must clearly attribute work done by the students and distinguish it from work done by others, including host labs, advisors, instructors, sponsors, professional website designers, artists, and commercial services</b></dt> | <dt><b>The description of each project must clearly attribute work done by the students and distinguish it from work done by others, including host labs, advisors, instructors, sponsors, professional website designers, artists, and commercial services</b></dt> | ||
- | <dd>We have compiled a complete list of <a href="https://2014.igem.org/Team:MIT/Attributions"> attributions </a></dd></dl></li> | + | <dd>We have compiled a complete list of <a href="https://2014.igem.org/Team:MIT/Attributions" style="color:teal"> attributions </a></dd></dl></li> |
<li><dl> | <li><dl> |
Revision as of 20:42, 17 October 2014
Home | Our Project | Lab Work | Outreach | About Us | Medals |
MEDALS | |
Gold Medal | |
| |
Silver Medal | |
| |
Bronze Medal | |
| |